Cart
sales@molnova.com
Mocravimod hydrochloride
CAS No. 509088-69-1
Mocravimod hydrochloride( KRP-203 )
Catalog No. M26300 CAS No. 509088-69-1
Mocravimod hydrochloride is an effecitive and orally active agonist of sphingosine 1-phosphate receptor type 1(S1PR1).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 173 | In Stock |
|
| 5MG | 163 | In Stock |
|
| 10MG | 264 | In Stock |
|
| 25MG | 535 | In Stock |
|
| 50MG | 811 | In Stock |
|
| 100MG | 1088 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMocravimod hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionMocravimod hydrochloride is an effecitive and orally active agonist of sphingosine 1-phosphate receptor type 1(S1PR1).
-
DescriptionMocravimod hydrochloride is an effecitive and orally active agonist of sphingosine 1-phosphate receptor type 1(S1PR1). (In Vivo):In mHC-disparate rat heart allografts, Mocravimod hydrochloride(orally; 0.1 and 1 mg/kg/day; for 100 days) prolongs graft survival and attenuates chronic rejection. Mocravimod hydrochloride ameliorates atherosclerosis in LDL-R(-/-) Mice.
-
In Vitro——
-
In VivoAnimal Model:Inbred male DA (MHC haplotype: RT1a) rats Dosage:0.1 and 1 mg/kg Administration:Orally; daily; for 100 days.Result:Prolonged graft survival and attenuated chronic rejection in mHC-disparate rat heart allografts.
-
SynonymsKRP-203
-
PathwayOthers
-
TargetOther Targets
-
Recptorgluconeogenesis
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number509088-69-1
-
Formula Weight480.44
-
Molecular FormulaC24H27Cl2NO3S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 200 mg/mL (416.28 mM)
-
SMILESCl.NC(CO)(CO)CCc1ccc(Sc2cccc(OCc3ccccc3)c2)cc1Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Murray AF, et, al. Phenylpropanoid Glycerol Glucosides Attenuate Glucose Production in Hepatocytes. ACS Omega. 2019 Jun 19;4(6):10670-10676.
molnova catalog
